Search

everythinglearnresearchcommunity

for

Search:↓

Targeting the skin's endocannabinoid system could help treat skin disorders.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Some breast cancer chemotherapy can cause permanent hair loss.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

Cetuximab can cause eyelash growth, which is rare but manageable.

Where melanoma is on the body affects survival chances; melanomas on the back of the head are worse, while those on thighs and arms are less severe, and more sun exposure might improve survival.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

A rare scalp condition mainly in older women can be treated with various alternatives to steroids, which may have fewer side effects.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Oral pigmentation can be a sign of Addison's disease.

A hormone linked to collagen helps hair grow back in mice after chemotherapy, and may also prevent bone loss.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

The treatment combination is effective and generally safe for lung cancer.

The conclusion is that Pigmented Epithelioid Melanocytoma can start from hair follicle stem cells or from a mole on the skin.

The conclusion is that dermatologists can improve women's skin health but must overcome cultural and economic barriers to do so.

All medications can cause skin rashes, often without a clear cause, and better tests are needed to identify these drug-related skin issues.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

A 65-year-old woman has a growing bald spot on her scalp.

A thorough skin history and full examination are important for diagnosing and understanding the impact of skin diseases.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

A rare case showed hair regrowth after chemotherapy for thymoma, suggesting a link between alopecia areata and thymoma.

Men with hair loss may have more body fat and different blood characteristics.